EPT Disclosure
21 Abril 2008 - 8:27AM
UK Regulatory
RNS Number:7530S
UBS AG (EPT)
21 April 2008
FORM 38.5(b)
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS
BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
(Rule 38.5(b) of the Takeover Code)
1. KEY INFORMATION
Name of exempt principal trader UBS AG London Branch
Company dealt in Whatman Plc
Class of relevant security to which the 0.1p ordinary
dealings being disclosed relate (Note 1)
Date of dealing 18 APRIL 2008
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 2)
Long Short
Number (%) Number (%)
(1) Relevant securities 12,646 0.01% 2,242 0.00%
(2) Derivatives (other than
options)
(3) Options and agreements to
purchase/sell
Total 12,646 0.01% 2,242 0.00%
(b) Interests and short positions in relevant securities of
the company, other than the class dealt in (Note 2)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than
options)
(3) Options and agreements to
purchase/sell
Total
(c) Rights to subscribe (Note 2)
Class of relevant security: Details
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note 4)
SALE 881 269 pence
PURCHASE 100 269
PURCHASE 100 269
PURCHASE 100 269
SALE 2636 269.25
SALE 115 269.25
SALE 88 269.25
SALE 85 269.25
SALE 20 269.25
SALE 11 269.25
SALE 2 269.25
PURCHASE 400 269.5
TOTAL PURCHASES: 700
TOTAL SALES: 3838
(b) Derivatives transactions (other than options)
Product name, e.g Long/short (Note 5) Number of securities Price per unit
CFD (Note 6) (Note 4)
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, e.g. Expiry Option
name,e.g. selling, securities price American, date money paid/
call purchasing, to which the European received per
option varying etc option etc. unit (Note
relates 4)
(Note 6)
(ii) Exercising
Product name, e.g. call Number of securities Exercise price per unit
option (Note 4)
(d) Other dealings (including new securities) (Note 3)
Nature of transaction Details Price per unit (if applicable)
(Note 7)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this should be
stated.
..............................................................................
..............................................................................
Is a Supplemental Form 38.5(b) attached? (Note 8)
NO
Date of disclosure 21 APRIL 2008
Contact name LOUISE ROBINSON
Telephone number 020 7567 8762
Name of offeree/offeror with which connected GE Healthcare Life Sciences Ltd
(a wholly owned General
Electric Company)
Nature of connection (Note 9) CONNECTED ADVISER
Notes
The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMBBGDSRDDGGIB
Whatman (LSE:WHM)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Whatman (LSE:WHM)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
Notícias em tempo-real sobre Whatman da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Whatman Plc